Addressing US FDA challenges in Indian sterile drug manufacturing – Part 1
Express Pharma
JUNE 19, 2025
Indian pharmaceutical companies supply more than 60 per cent of global demand for vaccines and over 40 per cent of generic medicines consumed in the United States (2). This growth is further driven by global shortages of sterile products, an expanding biologics pipeline, and the demand for emergency-use therapies including vaccines.
Let's personalize your content